Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

James Cantley pitched his GaitThaw project at the EIT Health Headstart/Proof-of-Concept Awards in Dublin on 5 September 2016, winning the award.

Dr. Cantley was one of  22 finalists in the competition, competing against other creative thinkers whose healthcare innovations may soon allow us to enjoy longer, more productive lives. He and his team were awarded a grant of €50 000 to help them turn their brilliant idea into a commercially viable businesses.

GaitThaw is a wearable device delivers with localized cues to prevent “gait freeze”, a common feature of Parkinson’s disease that reduces quality of life by impairing the ability to walk spontaneously and continuously.

Read more.

 

Similar stories

Winners of the DPAG Student Poster Day 2021 announced

"A Year of Progress" was held in the Sherrington Library and Sherrington PCR Café on Thursday 18 November 2021.

Oxford-led research maps milestone stage of human development for the first time

Scientists have shed light on an important stage of early embryonic development that has never been fully mapped out in humans before.

Wade-Martins Group achieves Bronze award for sustainable practices

The Wade-Martins Group has achieved a Laboratory Efficiency Assessment Framework (LEAF) Bronze award in recognition of its sustainable practices.

Mapping uncharted networks in the progression of Parkinson’s

A major new $9 million project funded by the Aligning Science Across Parkinson’s (ASAP) initiative will map the original circuits vulnerable to Parkinson’s on an unprecedented scale. The project is a collaboration between core investigators Stephanie Cragg, Richard Wade-Martins, and Peter Magill at Oxford, Mark Howe at Boston University and Dinos Meletis at the Karolinska Institutet, as well as collaborators Yulong Li at Peking University and Michael Lin at Stanford University.

Drug could help diabetic hearts recover after a heart attack

New research led by Associate Professor Lisa Heather has found that a drug known as molidustat, currently in clinical trials for another condition, could reduce risk of heart failure after heart attacks.